Viveve Medical, Inc. (VIVE) DCF Valuation

Viveve Medical, Inc. (VIVE) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Viveve Medical, Inc. (VIVE) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Take charge of your Viveve Medical, Inc. (VIVE) valuation analysis with our state-of-the-art DCF Calculator! Packed with real (VIVE) data, this Excel template enables you to adjust forecasts and assumptions for an accurate calculation of Viveve Medical's intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2017
AY2
2018
AY3
2019
AY4
2020
AY5
2021
FY1
2022
FY2
2023
FY3
2024
FY4
2025
FY5
2026
Revenue 15.3 18.5 6.6 5.5 6.4 5.7 5.1 4.6 4.1 3.7
Revenue Growth, % 0 21.12 -64.54 -16.57 17.28 -10.67 -10.67 -10.67 -10.67 -10.67
EBITDA -33.3 -44.2 -30.7 -18.5 -19.6 -5.7 -5.1 -4.6 -4.1 -3.7
EBITDA, % -218.09 -238.52 -467.17 -337.56 -305.51 -100 -100 -100 -100 -100
Depreciation .4 .8 1.2 1.3 1.1 .8 .7 .6 .5 .5
Depreciation, % 2.94 4.24 18 23.67 17.72 13.32 13.32 13.32 13.32 13.32
EBIT -33.8 -45.0 -31.9 -19.8 -20.8 -5.7 -5.1 -4.6 -4.1 -3.7
EBIT, % -221.02 -242.76 -485.17 -361.23 -323.23 -100 -100 -100 -100 -100
Total Cash 20.7 29.5 13.3 6.5 19.2 5.7 5.1 4.6 4.1 3.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.2 5.7 1.6 .8 .5
Account Receivables, % 40.64 30.8 23.95 14.05 8.54
Inventories 2.4 4.1 4.9 3.3 1.5 2.2 2.0 1.8 1.6 1.4
Inventories, % 15.63 22.24 74.02 59.39 22.91 38.84 38.84 38.84 38.84 38.84
Accounts Payable 4.8 4.0 1.6 .9 1.5 1.3 1.2 1.1 1.0 .9
Accounts Payable, % 31.39 21.57 24.49 16.08 23.03 23.31 23.31 23.31 23.31 23.31
Capital Expenditure -.9 -2.1 -1.1 -.8 -.5 -.6 -.6 -.5 -.5 -.4
Capital Expenditure, % -5.92 -11.57 -16.55 -14.25 -7.1 -11.08 -11.08 -11.08 -11.08 -11.08
Tax Rate, % -1.18 -1.18 -1.18 -1.18 -1.18 -1.18 -1.18 -1.18 -1.18 -1.18
EBITAT -33.5 -44.8 -35.5 -19.5 -21.0 -5.7 -5.1 -4.6 -4.1 -3.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -37.7 -48.2 -34.4 -17.3 -17.7 -7.3 -4.7 -4.2 -3.8 -3.4
WACC, % 18.52 18.64 18.69 18.44 18.69 18.6 18.6 18.6 18.6 18.6
PV UFCF
SUM PV UFCF -15.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -3
Terminal Value -21
Present Terminal Value -9
Enterprise Value -24
Net Debt -14
Equity Value -10
Diluted Shares Outstanding, MM 10
Equity Value Per Share -1.04

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Viveve Medical’s financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Genuine Viveve Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Parameters: Modify highlighted cells for metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
  • Suitable for All Skill Levels: An intuitive layout designed for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Viveve Medical's pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust assumptions.
  5. Step 5: Analyze the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for Viveve Medical, Inc. (VIVE)?

  • Designed for Experts: A sophisticated tool utilized by healthcare analysts, investors, and medical consultants.
  • Accurate Data: Viveve Medical’s historical and projected financials preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential metrics.
  • User-Friendly Interface: Step-by-step guidance makes the process straightforward.

Who Should Use This Product?

  • Investors: Evaluate Viveve Medical’s valuation before making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
  • Startup Founders: Understand the valuation practices of established medical technology companies like Viveve.
  • Consultants: Provide detailed valuation analysis and reports for healthcare clients.
  • Students and Educators: Utilize real-world case studies to learn and teach valuation principles.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Viveve Medical historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Viveve Medical, Inc. (VIVE).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.